Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy ; volume:9 ; number:1 ; day:17 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
EJNMMI Physics ; 9, Heft 1 (17.8.2022), 1-12, 12.2022
- Creator
-
Desy, Alessandro
Bouvet, Guillaume F.
Lafrenière, Nancy
Zamanian, Atefeh
Després, Philippe
Beauregard, Jean-Mathieu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-022-00484-w
- URN
-
urn:nbn:de:101:1-2022110420202395359328
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Desy, Alessandro
- Bouvet, Guillaume F.
- Lafrenière, Nancy
- Zamanian, Atefeh
- Després, Philippe
- Beauregard, Jean-Mathieu
- SpringerLink (Online service)
Other Objects (12)
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu‐PSMA therapy
Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu‐PSMA therapy
Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu‐PSMA therapy
Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands